ReseaRch Quality assuRance foR the futuRe a ... - Lund University

Panel 10 – medicine | Laboratory
The other 15 PIs at Department of Laboratory Medicine, Malmö are
characterized by originality, very good quality, productivity and impact in
their research
3.4 Collaboration
The Department of Laboratory Medicine, Malmö is steadily interacting
with the Department of Clinical Sciences at Malmö University Hospital.
There are plans to join the administrative offices to increase the effectiveness
and reduce the costs for the administration. Apart from this the
Department has no direct interaction with other departments.
The interaction with researchers in other departments and institutions at
Lund University is claimed to be “numerous” in the main document of
the evaluation material. However, there is no documentation or examples
of these interactions.
3.5 Research activities
The research activities at the Department of Laboratory Medicine,
Malmö are primarily related to two main areas: cancer and infection/
inflammation. A closer look at the research activities reveals that nine of
the D/Ss are involved in what could be defined as general tumor biology/
oncologic pathology. These include the D/S of Experimental Pathology
(PI: Tommy Andersson), D/S of Tumor Biology (PI: Pirkko Härkönen),
D/S of Pathology (PI: Göran Landberg), D/S of Molecular Medicine (PI:
Sven Påhlman) D/S of Tumor Cell Biology (PI: Christer Larsson), D/S
of Molecular Tumor Biology (PI: Håkan Axelson), D/S of Experimental
Clinical Chemistry (PI: Lars Rönnstrand), D/S of Cell Pathology (PI:
Anita Sjölander) and D/S of Experimental Cancer Research (PI: Jenny
Liao Persson).
The cancer area covers a number of topics including tumour invasion and
metastasis, Wnt and Notch signalling, specific inflammatory mediators,
cell cycle regulation, growth factor receptor signalling, genes expression
in tumor cells due to low oxygenation and/or reduced nutrient supply,
importance of virus infections in the etiology of cancer, preventive HPV
testing and HPV vaccination, and inflammatory conditions such as
ulcerative colitis leading to cancer.
290